CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Enanta Files Appeal in Ongoing Patent Dispute With Pfizer Over Paxlovid

Patent ExpiryPaxlovidNegative
AI Analysis

Summary

Enanta Pharmaceuticals has filed an appeal in its ongoing patent dispute with Pfizer regarding Paxlovid. The company is contesting patent-related issues concerning the antiviral treatment.

Importance:6/10
Sentiment:
-0.30
patent disputelegalintellectual propertyappealPaxlovid
Related Companies

Read the original article

Published by yahoo_finance on June 24, 2026 10:20 AM

Read Original